- In October 2024, Ambu Inc. received FDA clearance for its latest cystoscopy solution, the Ambu aScope 5 Cysto HD, alongside its two full-HD endoscopy systems, Ambu aBox 2 and Ambu aView 2 Advance. This clearance significantly impacts the cystoscopes market by expanding Ambu’s urology portfolio, providing U.S. healthcare professionals with advanced, high-definition, and flexible cystoscopy solutions. The approval is expected to enhance market competition and increase the adoption of innovative, minimally invasive diagnostic technologies in urology
- In January 2024, Boston Scientific announced the limited market release of its VersaVue single-use flexible cystoscope, after receiving FDA clearance in October. This development is poised to impact the cystoscopes market by offering a high-quality, disposable solution for clinicians diagnosing and treating urinary tract conditions. The introduction of the VersaVue cystoscope with its clear visualization capabilities is likely to boost demand for single-use cystoscopes, contributing to market growth as healthcare providers prioritize infection control and convenience
